{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:01:48Z","timestamp":1775142108731,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Sciences Foundation of China","doi-asserted-by":"crossref","award":["82074443"],"award-info":[{"award-number":["82074443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03600-1","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T22:20:46Z","timestamp":1736029246000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lipids, lipid-lowering drugs and the risk of herpes zoster: a Mendelian randomization study"],"prefix":"10.1007","volume":"317","author":[{"given":"Yuhui","family":"Che","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,4]]},"reference":[{"key":"3600_CR1","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1056\/NEJMcp013211","volume":"347","author":"JW Gnann Jr","year":"2002","unstructured":"Gnann JW Jr, Whitley RJ (2002) Clinical practice. Herpes zoster. N Engl J Med 347:340\u2013346. https:\/\/doi.org\/10.1056\/NEJMcp013211","journal-title":"N Engl J Med"},{"key":"3600_CR2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.2165\/00019053-199406020-00006","volume":"6","author":"L Davies","year":"1994","unstructured":"Davies L, Cossins L, Bowsher D, Drummond M (1994) The cost of treatment for post-herpetic neuralgia in the UK. Pharmacoeconomics 6:142\u2013148. https:\/\/doi.org\/10.2165\/00019053-199406020-00006","journal-title":"Pharmacoeconomics"},{"key":"3600_CR3","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.vaccine.2008.11.012","volume":"27","author":"AN Stein","year":"2009","unstructured":"Stein AN, Britt H, Harrison C, Conway EL, Cunningham A, Macintyre CR (2009) Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older. Vaccine 27:520\u2013529. https:\/\/doi.org\/10.1016\/j.vaccine.2008.11.012","journal-title":"Vaccine"},{"key":"3600_CR4","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1111\/j.1532-5415.2007.01231.x","volume":"55","author":"RH Dworkin","year":"2007","unstructured":"Dworkin RH, White R, O\u2019Connor AB, Baser O, Hawkins K (2007) Healthcare costs of acute and chronic pain associated with a diagnosis of herpes zoster. J Am Geriatr Soc 55:1168\u20131175. https:\/\/doi.org\/10.1111\/j.1532-5415.2007.01231.x","journal-title":"J Am Geriatr Soc"},{"key":"3600_CR5","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/bjd.14815","volume":"175","author":"A Matthews","year":"2016","unstructured":"Matthews A, Turkson M, Forbes H, Langan SM, Smeeth L, Bhaskaran K (2016) Statin use and the risk of herpes zoster: a nested case-control study using primary care data from the U.K. Clinical Research Practice Datalink. Br J Dermatol 175:1183\u20131194. https:\/\/doi.org\/10.1111\/bjd.14815","journal-title":"Br J Dermatol"},{"key":"3600_CR6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/cid\/cit745","volume":"58","author":"T Antoniou","year":"2014","unstructured":"Antoniou T, Zheng H, Singh S, Juurlink DN, Mamdani MM, Gomes T (2014) Statins and the risk of herpes zoster: a population-based cohort study. Clin Infect Dis\u202f: an official publication of the Infectious Diseases Society of America 58:350\u2013356. https:\/\/doi.org\/10.1093\/cid\/cit745","journal-title":"Clin Infect Dis : an official publication of the Infectious Diseases Society of America"},{"key":"3600_CR7","first-page":"483","volume":"59","author":"M Jasi\u0144ska","year":"2007","unstructured":"Jasi\u0144ska M, Owczarek J, Orszulak-Michalak D (2007) Statins: a new insight into their mechanisms of action and consequent pleiotropic effects. Pharmacol Rep\u202f: PR 59:483\u2013499","journal-title":"Pharmacol Rep : PR"},{"key":"3600_CR8","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G (2008) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27:1133\u20131163. https:\/\/doi.org\/10.1002\/sim.3034","journal-title":"Stat Med"},{"key":"3600_CR9","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/s0140-6736(05)67767-7","volume":"366","author":"A Hingorani","year":"2005","unstructured":"Hingorani A, Humphries S (2005) Nature\u2019s randomised trials. Lancet (London, England) 366:1906\u20131908. https:\/\/doi.org\/10.1016\/s0140-6736(05)67767-7","journal-title":"Lancet (London, England)"},{"key":"3600_CR10","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1136\/bmj.330.7499.1076","volume":"330","author":"G Davey Smith","year":"2005","unstructured":"Davey Smith G, Ebrahim S (2005) What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? BMJ (Clinical research ed) 330:1076\u20131079. https:\/\/doi.org\/10.1136\/bmj.330.7499.1076","journal-title":"BMJ (Clinical research ed)"},{"key":"3600_CR11","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith G, Hemani G (2014) Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet 23:R89-98. https:\/\/doi.org\/10.1093\/hmg\/ddu328","journal-title":"Hum Mol Genet"},{"key":"3600_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.12688\/wellcomeopenres.16544.2","volume":"6","author":"D Gill","year":"2021","unstructured":"Gill D, Georgakis MK, Walker VM, Schmidt AF, Gkatzionis A, Freitag DF, Finan C, Hingorani AD, Howson JMM, Burgess S et al (2021) Mendelian randomization for studying the effects of perturbing drug targets. Wellcome open research 6:16. https:\/\/doi.org\/10.12688\/wellcomeopenres.16544.2","journal-title":"Wellcome open research"},{"key":"3600_CR13","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, VanderWeele TJ, Higgins JPT, Timpson NJ, Dimou N et al (2021) Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. JAMA 326:1614\u20131621. https:\/\/doi.org\/10.1001\/jama.2021.18236","journal-title":"JAMA"},{"key":"3600_CR14","doi-asserted-by":"publisher","first-page":"e1003062","DOI":"10.1371\/journal.pmed.1003062","volume":"17","author":"TG Richardson","year":"2020","unstructured":"Richardson TG, Sanderson E, Palmer TM, Ala-Korpela M, Ference BA, Davey Smith G, Holmes MV (2020) Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable Mendelian randomisation analysis. PLoS Med 17:e1003062. https:\/\/doi.org\/10.1371\/journal.pmed.1003062","journal-title":"PLoS Med"},{"key":"3600_CR15","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41588-018-0058-3","volume":"50","author":"R Malik","year":"2018","unstructured":"Malik R, Chauhan G, Traylor M, Sargurupremraj M, Okada Y, Mishra A, Rutten-Jacobs L, Giese AK, van der Laan SW, Gretarsdottir S et al (2018) Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet 50:524\u2013537. https:\/\/doi.org\/10.1038\/s41588-018-0058-3","journal-title":"Nat Genet"},{"key":"3600_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41467-019-13690-5","volume":"11","author":"S Shah","year":"2020","unstructured":"Shah S, Henry A, Roselli C, Lin H, Sveinbj\u00f6rnsson G, Fatemifar G, Hedman AK, Wilk JB, Morley MP, Chaffin MD et al (2020) Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure. Nat Commun 11:163. https:\/\/doi.org\/10.1038\/s41467-019-13690-5","journal-title":"Nat Commun"},{"key":"3600_CR17","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/eurheartj\/ehaa1040","volume":"42","author":"JA Hartiala","year":"2021","unstructured":"Hartiala JA, Han Y, Jia Q, Hilser JR, Huang P, Gukasyan J, Schwartzman WS, Cai Z, Biswas S, Tr\u00e9gou\u00ebt DA et al (2021) Genome-wide analysis identifies novel susceptibility loci for myocardial infarction. Eur Heart J 42:919\u2013933. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa1040","journal-title":"Eur Heart J"},{"key":"3600_CR18","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG (2011) Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol 40:755\u2013764. https:\/\/doi.org\/10.1093\/ije\/dyr036","journal-title":"Int J Epidemiol"},{"key":"3600_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1136\/eb-2014-101794","volume":"17","author":"A Nikolakopoulou","year":"2014","unstructured":"Nikolakopoulou A, Mavridis D, Salanti G (2014) How to interpret meta-analysis models: fixed effect and random effects meta-analyses. Evid Based Ment Health 17:64. https:\/\/doi.org\/10.1136\/eb-2014-101794","journal-title":"Evid Based Ment Health"},{"key":"3600_CR20","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S (2016) Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 40:304\u2013314. https:\/\/doi.org\/10.1002\/gepi.21965","journal-title":"Genet Epidemiol"},{"key":"3600_CR21","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/sim.7221","volume":"36","author":"J Bowden","year":"2017","unstructured":"Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan N, Thompson J (2017) A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med 36:1783\u20131802. https:\/\/doi.org\/10.1002\/sim.7221","journal-title":"Stat Med"},{"key":"3600_CR22","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1093\/ije\/29.4.722","volume":"29","author":"S Greenland","year":"2000","unstructured":"Greenland S (2000) An introduction to instrumental variables for epidemiologists. Int J Epidemiol 29:722\u2013729. https:\/\/doi.org\/10.1093\/ije\/29.4.722","journal-title":"Int J Epidemiol"},{"key":"3600_CR23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG (2017) Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol 32:377\u2013389. https:\/\/doi.org\/10.1007\/s10654-017-0255-x","journal-title":"Eur J Epidemiol"},{"key":"3600_CR24","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 50:693\u2013698. https:\/\/doi.org\/10.1038\/s41588-018-0099-7","journal-title":"Nat Genet"},{"key":"3600_CR25","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s10096-015-2372-3","volume":"34","author":"HH Chen","year":"2015","unstructured":"Chen HH, Lin CL, Yeh CJ, Yeh SY, Kao CH (2015) Statins can increase the risk of herpes zoster infection in Asia. Eur J Clin Microbiol & Infect Dis\u202f: official publication of the European Society of Clinical Microbiology 34:1451\u20131458. https:\/\/doi.org\/10.1007\/s10096-015-2372-3","journal-title":"Eur J Clin Microbiol & Infect Dis : official publication of the European Society of Clinical Microbiology"},{"key":"3600_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198263","volume":"13","author":"MC Kim","year":"2018","unstructured":"Kim MC, Yun SC, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH (2018) Statins increase the risk of herpes zoster: a propensity score-matched analysis. PLoS ONE 13:e0198263. https:\/\/doi.org\/10.1371\/journal.pone.0198263","journal-title":"PLoS ONE"},{"key":"3600_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111268","volume":"9","author":"SD Chung","year":"2014","unstructured":"Chung SD, Tsai MC, Liu SP, Lin HC, Kang JH (2014) Herpes zoster is associated with prior statin use: a population-based case-control study. PLoS ONE 9:e111268. https:\/\/doi.org\/10.1371\/journal.pone.0111268","journal-title":"PLoS ONE"},{"key":"3600_CR28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.phrs.2017.04.008","volume":"120","author":"TP Johnston","year":"2017","unstructured":"Johnston TP, Korolenko TA, Pirro M, Sahebkar A (2017) Preventing cardiovascular heart disease: promising nutraceutical and non-nutraceutical treatments for cholesterol management. Pharmacol Res 120:219\u2013225. https:\/\/doi.org\/10.1016\/j.phrs.2017.04.008","journal-title":"Pharmacol Res"},{"key":"3600_CR29","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/s0140-6736(20)32332-1","volume":"396","author":"B Gencer","year":"2020","unstructured":"Gencer B, Marston NA, Im K, Cannon CP, Sever P, Keech A, Braunwald E, Giugliano RP, Sabatine MS (2020) Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials. Lancet (London, England) 396:1637\u20131643. https:\/\/doi.org\/10.1016\/s0140-6736(20)32332-1","journal-title":"Lancet (London, England)"},{"key":"3600_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1086\/649005","volume":"50","author":"JL Del Pozo","year":"2010","unstructured":"Del Pozo JL, van de Beek D, Mandrekar JN, Daly RC, McGregor CG, Azanza JR, Patel R (2010) High serum cholesterol levels are associated with herpes zoster infection after heart transplantation. Clin Infect Dis\u202f: an official publication of the Infectious Diseases Society of America 50:121\u2013122. https:\/\/doi.org\/10.1086\/649005","journal-title":"Clin Infect Dis : an official publication of the Infectious Diseases Society of America"},{"key":"3600_CR31","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1146\/annurev-biochem-081820-101010","volume":"90","author":"MM Schumacher","year":"2021","unstructured":"Schumacher MM, DeBose-Boyd RA (2021) Posttranslational regulation of HMG CoA reductase, the rate-limiting enzyme in synthesis of cholesterol. Annu Rev Biochem 90:659\u2013679. https:\/\/doi.org\/10.1146\/annurev-biochem-081820-101010","journal-title":"Annu Rev Biochem"},{"key":"3600_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/00041433-199402000-00010","volume":"5","author":"G Feussner","year":"1994","unstructured":"Feussner G (1994) HMG CoA reductase inhibitors. Curr Opin Lipidol 5:59\u201368. https:\/\/doi.org\/10.1097\/00041433-199402000-00010","journal-title":"Curr Opin Lipidol"},{"key":"3600_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/nejm198807073190105","volume":"319","author":"SM Grundy","year":"1988","unstructured":"Grundy SM (1988) HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. N Engl J Med 319:24\u201333. https:\/\/doi.org\/10.1056\/nejm198807073190105","journal-title":"N Engl J Med"},{"key":"3600_CR34","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/343425a0","volume":"343","author":"JL Goldstein","year":"1990","unstructured":"Goldstein JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature 343:425\u2013430. https:\/\/doi.org\/10.1038\/343425a0","journal-title":"Nature"},{"key":"3600_CR35","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nri1839","volume":"6","author":"J Greenwood","year":"2006","unstructured":"Greenwood J, Steinman L, Zamvil SS (2006) Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat Rev Immunol 6:358\u2013370. https:\/\/doi.org\/10.1038\/nri1839","journal-title":"Nat Rev Immunol"},{"key":"3600_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/187152807780077291","volume":"6","author":"R Ghittoni","year":"2007","unstructured":"Ghittoni R, Lazzerini PE, Pasini FL, Baldari CT (2007) T lymphocytes as targets of statins: molecular mechanisms and therapeutic perspectives. Inflamm Allergy Drug Targets 6:3\u201316. https:\/\/doi.org\/10.2174\/187152807780077291","journal-title":"Inflamm Allergy Drug Targets"},{"key":"3600_CR37","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.atherosclerosis.2007.07.031","volume":"197","author":"K Mausner-Fainberg","year":"2008","unstructured":"Mausner-Fainberg K, Luboshits G, Mor A, Maysel-Auslender S, Rubinstein A, Keren G, George J (2008) The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells. Atherosclerosis 197:829\u2013839. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2007.07.031","journal-title":"Atherosclerosis"},{"key":"3600_CR38","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1086\/515702","volume":"178","author":"DE Jenkins","year":"1998","unstructured":"Jenkins DE, Redman RL, Lam EM, Liu C, Lin I, Arvin AM (1998) Interleukin (IL)-10, IL-12, and interferon-gamma production in primary and memory immune responses to varicella-zoster virus. J Infect Dis 178:940\u2013948. https:\/\/doi.org\/10.1086\/515702","journal-title":"J Infect Dis"},{"key":"3600_CR39","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1086\/375056","volume":"36","author":"DS Fedson","year":"2003","unstructured":"Fedson DS (2003) Pandemic influenza and the global vaccine supply. Clin Infect Dis\u202f: an official publication of the Infectious Diseases Society of America 36:1552\u20131561. https:\/\/doi.org\/10.1086\/375056","journal-title":"Clin Infect Dis : an official publication of the Infectious Diseases Society of America"},{"key":"3600_CR40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.14712\/18059694.2016.63","volume":"53","author":"K Kond\u0115lkov\u00e1","year":"2010","unstructured":"Kond\u0115lkov\u00e1 K, Vokurkov\u00e1 D, Krejsek J, Borsk\u00e1 L, Fiala Z, Ctirad A (2010) Regulatory T cells (TREG) and their roles in immune system with respect to immunopathological disorders. Acta Med (Hradec Kralove) 53:73\u201377. https:\/\/doi.org\/10.14712\/18059694.2016.63","journal-title":"Acta Med (Hradec Kralove)"},{"key":"3600_CR41","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/ni1181","volume":"6","author":"Y Belkaid","year":"2005","unstructured":"Belkaid Y, Rouse BT (2005) Natural regulatory T cells in infectious disease. Nat Immunol 6:353\u2013360. https:\/\/doi.org\/10.1038\/ni1181","journal-title":"Nat Immunol"},{"key":"3600_CR42","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1161\/circulationaha.115.018531","volume":"133","author":"K Leander","year":"2016","unstructured":"Leander K, M\u00e4larstig A, Van\u2019t Hooft FM, Hyde C, Hell\u00e9nius ML, Troutt JS, Konrad RJ, \u00d6hrvik J, Hamsten A, de Faire U (2016) Circulating proprotein convertase subtilisin\/kexin type 9 (PCSK9) predicts future risk of cardiovascular events independently of established risk factors. Circulation 133:1230\u20131239. https:\/\/doi.org\/10.1161\/circulationaha.115.018531","journal-title":"Circulation"},{"key":"3600_CR43","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.jacl.2017.05.001","volume":"11","author":"CE Orringer","year":"2017","unstructured":"Orringer CE, Jacobson TA, Saseen JJ, Brown AS, Gotto AM, Ross JL, Underberg JA (2017) Update on the use of PCSK9 inhibitors in adults: recommendations from an Expert Panel of the National Lipid Association. J Clin Lipidol 11:880\u2013890. https:\/\/doi.org\/10.1016\/j.jacl.2017.05.001","journal-title":"J Clin Lipidol"},{"key":"3600_CR44","doi-asserted-by":"publisher","first-page":"12658","DOI":"10.1128\/jvi.79.20.12658-12666.2005","volume":"79","author":"JP Wang","year":"2005","unstructured":"Wang JP, Kurt-Jones EA, Shin OS, Manchak MD, Levin MJ, Finberg RW (2005) Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via toll-like receptor 2. J Virol 79:12658\u201312666. https:\/\/doi.org\/10.1128\/jvi.79.20.12658-12666.2005","journal-title":"J Virol"},{"key":"3600_CR45","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/j.1348-0421.2000.tb02599.x","volume":"44","author":"S Torigo","year":"2000","unstructured":"Torigo S, Ihara T, Kamiya H (2000) IL-12, IFN-gamma, and TNF-alpha released from mononuclear cells inhibit the spread of varicella-zoster virus at an early stage of varicella. Microbiol Immunol 44:1027\u20131031. https:\/\/doi.org\/10.1111\/j.1348-0421.2000.tb02599.x","journal-title":"Microbiol Immunol"},{"key":"3600_CR46","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.abd.2022.03.007","volume":"98","author":"D Lin","year":"2023","unstructured":"Lin D, Zhong C, Jiang Q, Huang A, Liu Y (2023) Serum interleukin-6 levels are increased in post-herpetic neuralgia: a single-center retrospective study. An Bras Dermatol 98:202\u2013207. https:\/\/doi.org\/10.1016\/j.abd.2022.03.007","journal-title":"An Bras Dermatol"},{"key":"3600_CR47","doi-asserted-by":"publisher","DOI":"10.4110\/in.2019.19.e41","volume":"19","author":"YU Kim","year":"2019","unstructured":"Kim YU, Kee P, Danila D, Teng BB (2019) A critical role of PCSK9 in mediating IL-17-producing T cell responses in hyperlipidemia. Immune network 19:e41. https:\/\/doi.org\/10.4110\/in.2019.19.e41","journal-title":"Immune network"},{"key":"3600_CR48","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1038\/s41598-018-20425-x","volume":"8","author":"C Ricci","year":"2018","unstructured":"Ricci C, Ruscica M, Camera M, Rossetti L, Macchi C, Colciago A, Zanotti I, Lupo MG, Adorni MP, Cicero AFG et al (2018) PCSK9 induces a pro-inflammatory response in macrophages. Sci Rep 8:2267. https:\/\/doi.org\/10.1038\/s41598-018-20425-x","journal-title":"Sci Rep"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03600-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03600-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03600-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T12:01:59Z","timestamp":1736078519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03600-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,4]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3600"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03600-1","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,4]]},"assertion":[{"value":"11 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This work used only publicly available genome-wide association study (GWAS) summary data. Ethical approval was obtained for all original studies with relevant citations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"166"}}